Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rudy

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Pharmacotherapy|January 27, 2004
Effect of fluticasone propionate nasal spray on bioavailability of intranasal hydromorphone hydrochloride in patients with allergic rhinitisGeorge A Davis, Anita C Rudy, Sanford M Archer, et al.
Journal of Clinical Pharmacology|July 20, 2005
Pharmacokinetics, bioequivalence, and spray weight reproducibility of intranasal butorphanol after administration with 2 different nasal spray pumpsDaniel P Wermeling, Jodi L Miller, Sanford M Archer, et al.
Clinical Drug Investigation|May 26, 2007
Bioavailability and pharmacokinetics of intranasal hydromorphone in patients experiencing vasomotor rhinitisGeorge A Davis, Anita C Rudy, Sanford M Archer, et al.
Journal of Neurochemistry|October 17, 2014
P301L tau expression affects glutamate release and clearance in the hippocampal trisynaptic pathwayHolly C Hunsberger, Carolyn C Rudy, Seth R Batten, et al.
American Journal of Therapeutics|November 1, 1995
The Influence of Misoprostol on the Adverse Renal Effects and Stereospecific Pharmacokinetics of Ibuprofen in Chronic Renal InsufficiencyD. W. Rudy, A. C. Rudy, P. K. Black, et al.
Anesthesia and Analgesia|July 25, 2006
Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteersDaniel P Wermeling, Kenneth A Record, Thomas H Kelly, et al.
Infection and Immunity|December 24, 1998
Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuriaR A Hull, D C Rudy, W H Donovan, et al.
Therapeutic Drug Monitoring|December 1, 1992
Variability in the disposition of ibuprofen enantiomers in osteoarthritis patientsA C Rudy, J D Bradley, S I Ryan, et al.
Urology|September 11, 2001
Pilot trial of bacterial interference for preventing urinary tract infectionR O Darouiche, W H Donovan, M Del Terzo, et al.
Clinical Drug Investigation|July 5, 2011
Pharmacokinetics of oxybutynin chloride topical gel: effects of application site, baths, sunscreen and person-to-person transferenceRoger R Dmochowski, Diane K Newman, Peter K Sand, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Pharmacotherapy|January 27, 2004
Effect of fluticasone propionate nasal spray on bioavailability of intranasal hydromorphone hydrochloride in patients with allergic rhinitisGeorge A Davis, Anita C Rudy, Sanford M Archer, et al.
Journal of Clinical Pharmacology|July 20, 2005
Pharmacokinetics, bioequivalence, and spray weight reproducibility of intranasal butorphanol after administration with 2 different nasal spray pumpsDaniel P Wermeling, Jodi L Miller, Sanford M Archer, et al.
Clinical Drug Investigation|May 26, 2007
Bioavailability and pharmacokinetics of intranasal hydromorphone in patients experiencing vasomotor rhinitisGeorge A Davis, Anita C Rudy, Sanford M Archer, et al.
Journal of Neurochemistry|October 17, 2014
P301L tau expression affects glutamate release and clearance in the hippocampal trisynaptic pathwayHolly C Hunsberger, Carolyn C Rudy, Seth R Batten, et al.
American Journal of Therapeutics|November 1, 1995
The Influence of Misoprostol on the Adverse Renal Effects and Stereospecific Pharmacokinetics of Ibuprofen in Chronic Renal InsufficiencyD. W. Rudy, A. C. Rudy, P. K. Black, et al.
Anesthesia and Analgesia|July 25, 2006
Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteersDaniel P Wermeling, Kenneth A Record, Thomas H Kelly, et al.
Infection and Immunity|December 24, 1998
Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuriaR A Hull, D C Rudy, W H Donovan, et al.
Therapeutic Drug Monitoring|December 1, 1992
Variability in the disposition of ibuprofen enantiomers in osteoarthritis patientsA C Rudy, J D Bradley, S I Ryan, et al.
Urology|September 11, 2001
Pilot trial of bacterial interference for preventing urinary tract infectionR O Darouiche, W H Donovan, M Del Terzo, et al.
Clinical Drug Investigation|July 5, 2011
Pharmacokinetics of oxybutynin chloride topical gel: effects of application site, baths, sunscreen and person-to-person transferenceRoger R Dmochowski, Diane K Newman, Peter K Sand, et al.
Pageof 8